Related Experiment Videos

Microbial growth and endotoxin production in the intravenous anesthetic propofol

M J Arduino1, L A Bland, S K McAllister

  • 1Hospital Infections Program, Centers for Disease Control, United States Department of Health and Human Services, Atlanta, Georgia.

Abstract

Insights

Propofol, an intravenous anesthetic, can support rapid microbial growth and endotoxin production. Strict aseptic techniques are crucial to prevent postsurgical infections linked to contaminated propofol.

Area of Science:

  • Microbiology
  • Anesthesiology
  • Infectious Diseases

Background:

  • Reports of postsurgical infections and pyrogenic reactions in 1990 were linked to contaminated propofol.
  • Investigations identified extrinsic contamination of the intravenous anesthetic as the probable source of outbreaks.

Purpose of the Study:

  • To measure microbial growth and endotoxin production in propofol.
  • To assess the risk of microbial contamination in intravenous anesthetic propofol.

Main Methods:

  • Ten microbial strains, including six from outbreak cases, were used.
  • Propofol samples were inoculated with microbial cultures and incubated at 30°C for 72 hours.

Main Results:

  • Nine of ten microbial cultures showed significant growth (3-6 logs) within 24 hours.
  • Escherichia coli, Enterobacter cloacae, and Acinetobacter calcoaceticus produced endotoxins within 24 hours.

Conclusions:

  • Propofol can support rapid microbial proliferation and endotoxin generation.
  • Meticulous aseptic technique is essential during propofol preparation and administration to prevent infectious complications.

Related Concept Videos